12-May-2023 | D | Recommended a final dividend of Rs. 0.50 per equity share (5%) of Rs. 10/- each for the
financial year ended 31% March, 2023.
As attached
(As Per BSE Announcement dated on 27.07.2023)
Fixes Record Date For Dividend
(As Per BSE Announcement Dated on 07.08.2023)
As attached.
This is in reference to our intimation done for book closure and record date vide letter dated
August 07, 2023 for determining shareholders entitled for final dividend.
In this regard, we would like to state that Company for same purpose has already made the
disclosure of book closure earlier on July 27, 2023 and which has also been taken on record
by Stock Exchange.
Thus, we hereby withdraw our intimation made on August 07, 2023 for book closure and
record date. The record date i.e. August 8, 2023 and corresponding book closure i.e. from August 9,
2023 to August 15, 2023 as intimated earlier in our letter dated July 27, 2023 shall be
considered as final.
(As Per BSE Announcement Dated on 09.08.2023) | 08-Aug-2023 | |
12-May-2022 | D | Board approved:
Recommended the final dividend of Rs. 0.75 per equity share (Rs. 7.50%) of Rs. 10/-
each for financial year ended March 31, 2022. The dividend, if declared by the shareholders in the of the ensuing agth Annual General Meeting GeneralCompany shall be paid to the shareholders within 30 days from the date of Annual Meeting.
Intimation of Record Date for the purpose of Final Dividend for the Financial Year 2021-22.
(As Per BSE Announcement Dated on 13/08/2022)
| 24-Aug-2022 | |
14-Jun-2021 | D | Recommended a final dividend of Rs. 0.5 per equity shares (5%) of Rs. 10/- each for the financial year ended March 31, 2021.
The dividend, if declared by the shareholders in the ensuing 28th Annual General Meeting of the Company shall be paid to the shareholders within 30 days from the date of Annual General Meeting.
| 02-Sep-2021 | |
02-Feb-2017 | R | Trading Members of the Exchange are hereby informed that, Archit Organosys Ltd. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Archit Organosys Ltd.
(524640)
RECORD DATE
11/02/2017
PURPOSE
Issue of 2 (TWO) equity shares of Rs. 10/- each on rights basis for cash at premium of Rs. 15/- per share for every 1 (ONE) equity share held.
Ex-Right basis from Date & Sett. No.
09/02/2017 DR-216/2016-2017
Trading Members of the Exchange are requested to take note of it. | 11-Feb-2017 | 2:1 |
16-Mar-2024 | BC | As attached
As attached.
(As Per BSE Announcement Dated on 03/04/2024) | 31-Mar-2024 | |
01-Apr-2024 | BC | Kandarp Krishnakant Amin & PACs | 28-Mar-2024 | |
27-Mar-2024 | BC | Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for disinvestment of Stake in Subsidiary LLP of the Company. | 27-Mar-2024 | |
01-Apr-2024 | BC | Archana Kandarp Amin & PACs | 27-Mar-2024 | |
05-Feb-2024 | BC | ARCHIT ORGANOSYS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Standalone & Consolidated un-audited | 14-Feb-2024 | |
Announcement Date12-May-2023
Ex Dividend Date08-Aug-2023
Dividend(%)5
Announcement Date12-May-2022
Ex Dividend Date24-Aug-2022
Dividend(%)8
Announcement Date14-Jun-2021
Ex Dividend Date02-Sep-2021
Dividend(%)5
No Bonus has been declared by Archit_Organosys
No Split has been declared by Archit_Organosys
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)15
Ratio2:1
Book Closure
31-Mar-2024 | - | As attached
As attached.
(As Per BSE Announcement Dated on 03/04/2024) |
28-Mar-2024 | - | Kandarp Krishnakant Amin & PACs |
27-Mar-2024 | - | Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for disinvestment of Stake in Subsidiary LLP of the Company. |
27-Mar-2024 | - | Archana Kandarp Amin & PACs |
14-Feb-2024 | - | ARCHIT ORGANOSYS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Standalone & Consolidated un-audited |